ChemX Materials Limited (CMX.AX)
AUD 0.03
(0.0%)
AUD 0.03
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | - | - | - | - |
| Cost of Revenue | 277.92 Thousand | 251.33 Thousand | 65.04 Thousand | - |
| Gross Profit | -277.92 Thousand | -251.33 Thousand | -65.04 Thousand | - |
| Operating Expenses | 4.12 Million | 4.84 Million | 2.2 Million | 117.31 Thousand |
| Selling, General and Administrative Expenses | 4.12 Million | 4.84 Million | 1.51 Million | 117.31 Thousand |
| Research and Development Expenses | - | - | - | - |
| Other Expenses | - | 782.23 Thousand | 315.49 Thousand | - |
| Cost and Expenses | 4.4 Million | 5.09 Million | 2.2 Million | 117.31 Thousand |
| Operating Income | -4.4 Million | -5.09 Million | -2.2 Million | -117.32 Thousand |
| Interest Expense | 809.79 Thousand | 36.26 Thousand | - | - |
| Income Tax Expense | 727.31 Thousand | -1.00 | -412.00 | -236.55 Thousand |
| Earnings before Tax | -4.48 Million | -4.18 Million | -1.88 Million | -117.31 Thousand |
| Net Income | -4.48 Million | -4.18 Million | -1.88 Million | -117.31 Thousand |
| Earnings Per Share Basic | -0.04 | -0.05 | -0.02 | -0.00 |
| Earnings Per Share Diluted | -0.04 | -0.05 | -0.02 | -0.00 |
| Weighted Average Shares Outstanding | 101.08 Million | 92.77 Million | 90.77 Million | 90.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 101.08 Million | 92.77 Million | 90.77 Million | 90.77 Million |
| Gross Margin | - | - | - | - |
| EBIT Margin | - | - | - | - |
| Profit Margin | - | - | - | - |
| EBITDA | -3.39 Million | -3.89 Million | -1.82 Million | -117.32 Thousand |
| Earnings Before Tax Margin | - | - | - | - |
| Breakdown | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | 140.57 Thousand | 251.33 Thousand | 110.75 Thousand | 65.04 Thousand |
| Gross Profit | - | - | -140.57 Thousand | -251.33 Thousand | -110.75 Thousand | -65.04 Thousand |
| Operating Expenses | 2.49 Million | 1.9 Million | 2.35 Million | 4.84 Million | 2.48 Million | 1.47 Million |
| Selling, General and Administrative Expenses | 2.49 Million | 1.9 Million | 2.35 Million | - | 2.48 Million | 1.47 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | 782.23 Thousand | - | - |
| Cost and Expenses | 2.49 Million | 1.9 Million | 2.49 Million | 5.09 Million | 2.59 Million | 1.54 Million |
| Operating Income | -2.49 Million | -1.9 Million | -2.49 Million | -5.09 Million | -2.59 Million | -1.54 Million |
| Interest Expense | 572.6 Thousand | 237.19 Thousand | 21.9 Thousand | 36.26 Thousand | 14.36 Thousand | - |
| Income Tax Expense | - | - | -2.00 | -1.00 | 2.00 | -3.00 |
| Earnings before Tax | -2.57 Million | -1.91 Million | -1.73 Million | -4.18 Million | -2.44 Million | -1.19 Million |
| Net Income | -2.57 Million | -1.91 Million | -1.73 Million | -4.18 Million | -2.44 Million | -1.19 Million |
| Earnings Per Share Basic | -0.02 | -0.02 | -0.02 | - | -0.03 | -0.01 |
| Earnings Per Share Diluted | -0.02 | -0.02 | -0.02 | - | -0.03 | -0.01 |
| Weighted Average Shares Outstanding | 106.43 Million | 94.68 Million | 92.77 Million | 92.77 Million | 92.77 Million | 90.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 106.43 Million | 94.68 Million | 92.77 Million | 92.77 Million | 92.77 Million | 90.77 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -2 Million | -1.9 Million | -2.35 Million | - | -2.48 Million | -1.47 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
TXLZF
URANF
1302
URAL
CLGPF
603936